Paclitaxel, carboplatin and gemcitabine (PCG) as neoadjuvant therapy in patients with locally advanced transitional cell carcinoma (TCC) of the bladder.

被引：0
|
作者：
Smith, DC
Bhandari, M
Hussain, M
Montie, JE
Wood, DP
Lee, CT
Petrylak, DP
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Columbia Presbyterian Med Ctr, New York, NY USA
[3] Wayne State Univ, Detroit, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4541
引用
收藏
页码：392S / 392S
页数：1
相关论文
共 50 条
  • [21] Pharmacogenetics determinants of anticancer activity of intravescical gemcitabine in patients with superficial transitional cell carcinoma (TCC) of the bladder
    De Braud, Filippo
    Danesi, Romano
    Curigliano, Giuseppe
    Giovanetti, Elisa
    De Cobelli, Ottavio
    De Pas, Tommaso
    Mey, Valentina
    Spitaleri, Gianluca
    Pece, Salvatore
    Noberasco, Cristina
    Nannizzi, Sara
    Verweij, Fabrizio
    Renne, Giuseppe
    McVie, Gordon
    Del Tacca, Mario
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [22] Gemcitabine and paclitaxel combination therapy in transitional cell carcinoma of the urothelium
    Meluch, A. A.
    Burris, H. S.
    Greco, F. A.
    Hainsworth, J. D.
    [J]. EUROPEAN JOURNAL OF CANCER, 2000, 36 : S30 - S33
  • [23] Carboplatin-gemcitabine treatment of patients with transitional cell carcinoma of the bladder and impaired renal function
    Carles, J
    Nogué, M
    Domènech, M
    Pérez, C
    Saigí, E
    Villadiego, K
    Guasch, I
    Ibeas, R
    [J]. ONCOLOGY, 2000, 59 (01) : 24 - 27
  • [24] Chemotherapy with gemcitabine, paclitaxel, and cisplatin in the treatment of patients with advanced transitional cell carcinoma of the urothelium
    Ecke, Thorsten H.
    Bartel, Peter
    Koch, Stefan
    Ruttloff, Juergen
    Theissig, Franz
    [J]. ONCOLOGY REPORTS, 2006, 16 (06) : 1381 - 1388
  • [25] Gene expression profile of advanced squamous and transitional cell carcinoma of the bladder.
    Khaled, H. M.
    Abu-Taleb, F.
    Zekri, A.
    Haggag, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [26] NEOADJUVANT METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN FOR LOCALLY ADVANCED TRANSITIONAL CELL-CARCINOMA OF THE BLADDER
    MILLER, RJ
    BAHNSON, RR
    BANNER, B
    ERNSTOFF, MS
    ODONNELL, WF
    [J]. CANCER, 1990, 65 (02) : 207 - 210
  • [27] Gemcitabine (GEM) and cisplatin (Cis) in advanced/metastatic transitional cell carcinoma (TCC) of bladder:: Phase II study.
    Adamo, V
    D'Angelo, A
    Ferraro, G
    Alafaci, E
    Altavilla, G
    Garipoli, C
    Magno, C
    Scimone, A
    Zanghì, M
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 79 - 79
  • [28] Phase II multicenter trial of belinostat (PXD101) in combination with carboplatin and paclitaxel (BelCaP) for patients (pts) with transitional cell carcinoma (TCC) of the bladder
    Barriuso, J.
    Daugaard, G.
    Frentzas, S.
    Fuglsang, L.
    Glasspool, R.
    Krarup-Hansen, A.
    Jones, R. J.
    Lassen, U.
    Sengelov, L.
    De Bono, J. S.
    [J]. EJC SUPPLEMENTS, 2008, 6 (12): : 67 - 68
  • [29] Gemcitabine and carboplatin chemotherapy in advanced transitional cell carcinoma in regard to patients with impaired renal function
    Helke, C.
    May, M.
    Hoschke, B.
    [J]. AKTUELLE UROLOGIE, 2006, 37 (05) : 363 - 368
  • [30] Survival of tumor cells in irrigation fluids during endoscopic resection of transitional cell carcinoma (TCC) of the bladder.
    不详
    [J]. JOURNAL OF ENDOUROLOGY, 2005, 19 : A3 - A3
12345